Rifapentine PopPK model in Chinese adults
Indication: Tuberculosis treatment and latent TB infection prophylaxis
Population pharmacokinetic simulator for rifapentine in Chinese adults. Rifapentine is a long-acting rifamycin antibiotic that inhibits bacterial RNA polymerase, used for tuberculosis treatment and latent TB prophylaxis. Explore dose-exposure relationships and covariate effects on rifapentine PK.
Drug Overview
Clinical Context
- Molecular Target
- RNA polymerase (bacterial)
- Drug Class
- Rifamycin antibiotic
- Therapeutic Area
- Infectious Disease - Tuberculosis
- Indication
- Tuberculosis treatment and latent TB infection prophylaxis
- Route of Administration
- Oral
Model Information
- Model Type
- PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Rifapentine allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK model characterizes the pharmacokinetics of this rifamycin antibiotic following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Rifapentine PK simulator?
This is a free, interactive pharmacokinetic simulator for Rifapentine used in Tuberculosis treatment and latent TB infection prophylaxis. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Rifapentine belong to?
Rifapentine is classified as a Rifamycin antibiotic that targets RNA polymerase (bacterial). It is used in the Infectious Disease - Tuberculosis therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of Rifapentine. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the Rifapentine simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community